The Alabama Department of Public Health has stated that allocation quantities of Paxlovid and Lagevrio (molnupiravir) have increased. ADPH has expanded access to most of the chain pharmacies and several independent pharmacies. If you are interested in being an oral antiviral provider, please review the information below.
Pharmacies interested in dispensing Paxlovid and/or Lagevrio (molnupiravir) for the treatment of COVID-19 should send an email to pharmacy@adph.state.al.us. The Pharmacy Division at the Alabama Department of Public Health will provide information and assist with setting up an HPOP account which is required by HHS. Through this account, pharmacies will report utilization daily which is also required by HHS. The Fact Sheet for Paxlovid can be found here. The Fact Sheet for Lagevrio (molnupiravir) can be found here.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.